Key result
Cholesterol-based screening for familial hypercholesterolemia appears feasible only from age 1 due to LDL-C overlap.
Why the study?
Is cholesterol-based screening feasible for identifying familial hypercholesterolaemia in newborns and children?
Observational
Is cholesterol-based screening feasible for identifying familial hypercholesterolaemia in newborns and children?
Answers are grounded in this paper and cite their sources.
Cholesterol-based screening for familial hypercholesterolemia is only feasible from 1 year of age onward due to significant LDL-C overlap between FH and non-FH infants.
Previous studies investigating lipid or genetic screening approaches for FH have limitations of only performing genetic testing in children with high LDL-C levels. The present study is the first to show the true LDL-C overlap in children with FH vs non-FH by utilizing unique data from a national family cascade screening programme. Cholesterol-based screening approaches for FH only seem feasible from 1 year of age onward.
No takes yet. Share an insight, caveat, or question.
Bogsrud et al. (2025) conducted an observational in Familial hypercholesterolaemia. Genetically verified familial hypercholesterolaemia vs. Non-FH was evaluated on LDL-C overlap. Cholesterol-based screening approaches for familial hypercholesterolaemia only seem feasible from 1 year of age onward due to LDL-C overlap between children with and without FH.
Synapse has enriched 10 related papers. Consider them for comparative context: